CARDIAC INVOLVEMENT IN IRAQI PATIENTS WITH SYSTEMIC SCLEROSIS (SCLERODERMA).
- Al-Shammari M A, M.B.ch.B, D.R. &Reh., Specialist Doctor in Rheumatology and Rehabilitation. Al-Yarmouk Teaching Hospital Baghdad/Iraq.
- Al-Izzi M., Proff. , M.R.C.P (U.K), F.R.C.P (EDIN.). Medicine Prof. College of Medicine, University of Baghdad.
11 Downloads
85 Views
Abstract
Background: Systemic sclerosis (Scleroderma) is a chronic multisystem disease of unknown etiology, has been considered a disease of metabolic disorder of connective tissue.
Methodology: A case control study. Thirty patients with systemic sclerosis forming the study group and twenty healthy individuals as a control group. Chest X-ray, electrocardiogram, and echocardiography were done for both groups for cardiac evaluation.
Results: The incidence of cardiac abnormality among patients group was (66.7%) in comparison to the control group (20%) (p = 0.001). Also there was an increase in the incidence of pericardial abnormalities (23.3%) and mitral valve thickening (33.3%) amongsclerodermic patients than control group (0%, 5%) respectively. There was a significant difference (P = 0.053) in the occurrence of cardiac involvement among diffuse scleroderma (75%) than limited one (33.3%).
Conclusion: Cardiac abnormalities affect more than half of patients with systemic sclerosis. These abnormalities appear to be more frequent in patients with diffuse scleroderma than in limited one.
Keywords
Article Analytics
References
1. White, B., andWigly, FM. (2001): Epidemiology and clinical feature of systemic sclerosis. In: Kipple JH., Primer on the rheumatic diseases, 12thed, Atlanta, Georgia: Arthritis foundation: 353-364.
2. Goldman, A., and Kotler, M. (1985): Heart disease in scleroderma. Am Heart J., 110:1043-46.
3. Botstein, G.R., and Leroy, E.C. (1981): Primary heart disease in systemic sclerosis (scleroderma): Advance in clinical and pathological features, pathogenesis and new therapeutic approaches. Am Heart dis., 102: 913-919.
4. Janosik, D.L., Osborn, T.G., Moore, T.L., Shah, D.G., Kenney R.G., and Zuckner, J.(1989): Heart disease in systemic sclerosis. ArthritisRheum., 19(3): 191-200.
5. Kostis, J.B., Seibold, J.R., Turkevich, D.,Masi, A.T., Grau, R.G.,Medsger, T.A., et al. (1988): Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med., 84:1007-1015.
6. Siebold, J.R., (1997): Scleroderma In: Kelly, W.N., Ruddy, S., Harris, E.D., Sledyle, C.B. Textbook of rheumatology, 5th ed. Philadelphia: WB Saunders Co. pp 1133-58.
7. Botrous, G.S., Dowd, P.M., Milne, J., andDymond, D.S. (1985): Non-invasive assessment of early cardiac involvement in systemic sclerosis. Postgrad MedJ., 61:679-84.
8. Smith, J.W., Clements, P.J., Levisman, J., Furst, D., et al. (1979): Echocardiographic features of progressivesystemic sclerosis. Am J Med., 66: 23-33
9. Badui, E., Robles, E., Hernande, Z. C., et al. (1985): Cardiovascular manifestation in progressive systemic sclerosis. Arch InstCardiol Mex., 55(3): 263-8 [Abstract]
10. Dubeeq, S., Constants, J., Pellgrine, J.L., et al. (1993): Cardiac involvement in scleroderma; study with echocardiography and cardiac Doppler in 38 patients. Rev Med Interne., 14(10):937. [Abstract]
11. Riera, JC, Gil LS., Simeon, CP., et al. (1996): Comprehensive non-invasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum., 39(7): 1138-45.
12. Hata, N., Kunimi, T., Mastsuda, H., et al. (1998): Cardiac disorders associated with progressive systemic sclerosis. J Cardiology., 32(6): 397-402.
13. Valentini, G., Vitale, D.F., Giunta A., et al. (1996): Diastolic abnormalities in systemic sclerosis. Ann Rheum Dis., 55(7): 455-60.
14. Giunt, A., Terri, E., Maione, S., et al. (2000): Right ventricular diastolic annormalityin systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis., 59(2): 94-8.
15. Morelli, S., Sgreccia, A., Ferrante, L., et al. (1996): Relationships between electrocardiographic and echocardiographic finding in systemic sclerosis (scleroderma). IntJ Cardiology., 57(2): 151-60. [Abstract]
16. Deswal, A., Follansbee, W.P., Cardiac involvement in scleroderma. (1996):Rheu Dis Clin North Am., 22(4): 841-60. [Abstract].
17. Kuwanon, M., Kaburaki, J., Okano, Y., et al. (1994): Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum., 37(1): 75-83
18. Weiner, E.S., Earnshaw, W.C., Senecal, J.L., et al. (1988): Clinical association of anticentromere antibodies and antibodies to topoisomerase 1. Arthritis Rheum., 31(3): 378-85.
19. Follansbee, W.P., (1986): The cardiovascular manifestations of systemic sclerosis. Current Problem Cardiology., 11(5): 241-98.
20. Tan, E.M., Rodnan, G.P., Garcia, I., et al. (1980): Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum., 23(6): 617-25.
21. Firtzler, M.J., Kinsella, T.D. (1980): The CREST syndrome a distinct serologic entity with anticentromer antibodies. Am J Med., 69:520-25.
22. Handa, R., Gupta, K., Malhotra, A., et al. (1999): Cardiac involvement in limited systemic sclerosis: Non-invasive assessment in asymptomatic patients. Clin Rheumatology., 18(2): 136-39.
How to Cite This Article
Mohammed Ali Al-shammari and Mustafa Al-Izzi. (2018); CARDIAC INVOLVEMENT IN IRAQI PATIENTS WITH SYSTEMIC SCLEROSIS (SCLERODERMA)., Int. J. of Adv. Res., 6 (10), 1390-1396, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/7947
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.